Medtronic Exec Will Bring Device Perspective To Clinical Trials Coalition
This article was originally published in The Gray Sheet
Executive Summary
With a broad-based and seasoned executive board in place, the recently formed FDA/Duke University partnership aimed at improving clinical trials is gaining momentum and seeking to fill out its ranks
You may also be interested in...
Research Backlash: Does FDA Have A PMA Problem?
In the wake of recent reviews criticizing the quality of pre-market cardiac device trials, FDA, industry, clinicians and others are debating what reforms are necessary to PMA study standards
Research Backlash: Does FDA Have A PMA Problem?
In the wake of recent reviews criticizing the quality of pre-market cardiac device trials, FDA, industry, clinicians and others are debating what reforms are necessary to PMA study standards
Sponsors Rein In Clinical Trial Violation Rate, But Monitoring Is Problematic
Despite improvements in sponsors' compliance with clinical trial regulations last year, trial monitoring continues to be an issue, according to CDRH